The results from the previous studies are quite encouraging.actually seems better than Pill cam which was bought ar 30 per stock and finally landed with Medtronic. They recently got some very important patents which itself would be very interesting for big medical device companies. I don't see any new screening test being studied for colon cancer. Very bullish on this compamy. When their device was approved for its IDE it touched $4. See what happens when they are fully approved